PMID: 7020916Jun 1, 1981Paper

DTIC and combination therapy for melanoma: III. DTIC (NSC 45388) Surgical Adjuvant Study COG PROTOCOL 7040

Cancer
G J HillE T Krementz

Abstract

A prospectively randomized study of postoperative chemotherapy with dimethyl triazeno imidazole carboxamide (DTIC) was conducted by the Central Oncology Group from 1972 until 1976. Of 174 patients operated upon for melanoma and entered into the study, 87 were randomly selected to receive DTIC, four courses in 12 months, at 4.5 mg/kg/d x 10. One-hundred-sixty-five (95%) of the cases were evaluable, including 40 high risk Stage I, 96 Stage II, and 29 Stage III cases. At a median follow-up period of 2.5 years, the control group had a better median disease-free interval (40 weeks vs. 73 weeks), median survival time (103 weeks vs. 133 weeks), and percentage of patients living free of disease (28% vs. 44%) than the DTIC-treated group. While disease-free interval appeared to be improved in the 25% of patients on DTIC therapy who developed thrombocytopenia, the overall effect of postoperative DTIC therapy was apparently not beneficial (P less than 0.05).

Citations

Aug 24, 2006·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·A Hauschild, U R Kleeberg
Jun 1, 2010·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·K C KählerA Hauschild
Sep 17, 2005·HNO·E S Schultz, G Schuler
May 15, 2003·The Surgical Clinics of North America·Charles Komen Brown, John M Kirkwood
Mar 1, 1991·Ophthalmology·E S GragoudasM D Spar
Apr 1, 1996·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·N Cascinelli
Dec 16, 1998·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A M Eggermont
Oct 30, 2001·Critical Reviews in Oncology/hematology·S Retsas
Oct 26, 2002·Critical Reviews in Oncology/hematology·R Molife, B W Hancock
Mar 14, 2003·Critical Reviews in Oncology/hematology·Timothy M Pawlik, Vernon K Sondak
Aug 27, 2005·The Surgeon : Journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·D KavanaghN J O'Higgins
Oct 7, 1982·The New England Journal of Medicine·U VeronesiR Tomin
Sep 25, 2001·The Laryngoscope·E J Lentsch, J N Myers
Jul 11, 2007·The Cancer Journal·Gaurav D Shah, Paul B Chapman
Mar 14, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Silvy da Rocha DiasFrancesco Pignatti
Feb 3, 2009·The Surgical Clinics of North America·Katharine YaoDavid J Winchester
Feb 1, 1990·Journal of the American Academy of Dermatology·V C Ho, A J Sober
Nov 23, 2006·Current Problems in Surgery·Cecelia E SchmalbachCarol R Bradford
Aug 1, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·C Lévy-SitbonF Grange
Dec 4, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·T MatsumotoM Akiyama
Jan 1, 1993·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·C Karakousis, L Blumenson
Sep 1, 1987·Journal of Surgical Oncology·C P Karakousis, L J Emrich
Dec 1, 1987·Journal of Surgical Oncology·C P Karakousis, L J Emrich
Jan 1, 1985·Medical and Pediatric Oncology·H K KohR W Carey
Nov 2, 1999·Cancer Treatment Reviews·S ChowdhuryM E Gore
Jan 15, 1995·Cancer·A Barth, D L Morton
Mar 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M F AvrilY Menu
Jan 1, 2010·Cancers·Elias G EliasBhuvnesh K Sharma
Sep 1, 1984·Cancer·S R BorjaJ P Cahill
May 20, 1998·Seminars in Surgical Oncology·S S Agarwala, J M Kirkwood
May 30, 2003·Seminars in Cutaneous Medicine and Surgery·Larisa GeskinJohn M Kirkwood
Aug 1, 1984·The Australian and New Zealand Journal of Surgery·P Hersey, C M Balch
Nov 1, 2005·Cancer Control : Journal of the Moffitt Cancer Center·David H Lawson
May 31, 2020·Cancer Treatment Reviews·Tara D BaetzTeresa M Petrella
Jul 1, 1987·The American Journal of the Medical Sciences·B L Powell, J B Craig
Jan 1, 1986·Medical Oncology and Tumor Pharmacotherapy·L E Spitler

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.